In a sedentary world the power of supervised exercise programs to improve medical outcomes is being recognized in novel areas. The CR model of structured exercise, group socialization, education, support and medical supervision has improved outcomes in PAD and CHF populations. There is now a strong base of support in the medical literature to apply the lessons learned from Cardiac, Pulmonary, PAD and CHF populations to new populations. Cardiac and Pulmonary rehabilitation providers are ideally suited to lead the development of parallel programs in novel populations. Potential targets for research and program development are stroke, vascular disease, cancer, obese and psychiatric patient populations. Although there is not currently established reimbursement for these populations programs there are alternate ways to fund novel programs in the institutional setting. This presentation will review the evidence base that allowed expansion of coverage from mostly CAD and COPD populations to include advanced heart disease and PAD. We will provide an overview of new target populations and highlight common institutional priorities and how they can be used to obtain new resources to pilot novel treatment paths. We will share examples of data collection tools that can be used for either Performance Improvement or research projects, and we will discuss what kind of data is most useful in advancing application of the supervised exercise model to new patient populations to achieve successful behavior modification and meaningful secondary prevention.
Please note, if you claimed credit for this session during the live annual meeting or the access period to recorded webinars, you cannot claim credit for this session again.
Presented by: Anne F. Ambrose, MD, Matthew N. Bartels, MD, MPH; David Z. Prince, MD, FAAPMR
In a sedentary world the power of supervised exercise programs to improve medical outcomes is being recognized in novel areas. The CR model of structured exercise, group socialization, education, support and medical supervision has improved outcomes in PAD and CHF populations. There is now a strong base of support in the medical literature to apply the lessons learned from Cardiac, Pulmonary, PAD and CHF populations to new populations. Cardiac and Pulmonary rehabilitation providers are ideally suited to lead the development of parallel programs in novel populations. Potential targets for research and program development are stroke, vascular disease, cancer, obese and psychiatric patient populations. Although there is not currently established reimbursement for these populations programs there are alternate ways to fund novel programs in the institutional setting. This presentation will review the evidence base that allowed expansion of coverage from mostly CAD and COPD populations to include advanced heart disease and PAD. We will provide an overview of new target populations and highlight common institutional priorities and how they can be used to obtain new resources to pilot novel treatment paths. We will share examples of data collection tools that can be used for either Performance Improvement or research projects, and we will discuss what kind of data is most useful in advancing application of the supervised exercise model to new patient populations to achieve successful behavior modification and meaningful secondary prevention.
Learning Objectives:
- Highlight the most impactful evidence in the medical literature to support discussions regarding expansion of the CR/PR model of care.
- Discuss novel patient population targets for supervised exercise program development.
- Elucidate common institutional goals and identify funding opportunities for new programs as well as best practices for “pitch strategies.”
- Empower participants to collect meaningful data for presentation to support funding for novel programs.
| Title | Credit(s) | |
|---|---|---|
| 1 | ||
| 2 | ||
| 3 | ||
| 4 |